Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:BCPC
CUSIP05766520
Phone845-326-5600
Debt
Debt-to-Equity Ratio0.28
Current Ratio2.16
Quick Ratio1.48
Price-To-Earnings
Trailing P/E Ratio36.51
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$594.79 million
Price / Sales5.36
Cash Flow$3.9502 per share
Price / Cash25.12
Book Value$19.27 per share
Price / Book5.15
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$90.07 million
Net Margins15.18%
Return on Equity14.50%
Return on Assets9.03%
Miscellaneous
Employees1,165
Outstanding Shares32,110,000
Balchem (NASDAQ:BCPC) Frequently Asked Questions
What is Balchem's stock symbol?
Balchem trades on the NASDAQ under the ticker symbol "BCPC."
How often does Balchem pay dividends? What is the dividend yield for Balchem?
Balchem announced an annual dividend on Wednesday, December 13th. Stockholders of record on Wednesday, December 27th will be paid a dividend of $0.42 per share on Friday, January 19th. This represents a dividend yield of 0.5%. The ex-dividend date is Tuesday, December 26th. This is a boost from Balchem's previous annual dividend of $0.38. View Balchem's Dividend History.
How were Balchem's earnings last quarter?
Balchem Co. (NASDAQ:BCPC) issued its quarterly earnings results on Friday, May, 4th. The basic materials company reported $0.76 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.70 by $0.06. The basic materials company had revenue of $161.41 million for the quarter. Balchem had a net margin of 15.18% and a return on equity of 14.50%. View Balchem's Earnings History.
When is Balchem's next earnings date?
What price target have analysts set for BCPC?
2 brokerages have issued 1 year price objectives for Balchem's stock. Their predictions range from $85.00 to $85.00. On average, they anticipate Balchem's share price to reach $85.00 in the next twelve months. View Analyst Ratings for Balchem.
Who are some of Balchem's key competitors?
Some companies that are related to Balchem include FMC (FMC), JOHNSON MATTHEY/S (JMPLY), Chemours (CC), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Ingevity (NGVT), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP), KMG Chemicals (KMG), OCI Partners (OCIP) and Innophos (IPHS).
Who are Balchem's key executives?
Balchem's management team includes the folowing people:
- Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 53)
- Ms. Mary Theresa Coelho, Chief Financial Officer and Treasurer (Age 56)
- Mr. William A. Backus CPA, Chief Accounting Officer (Age 52)
- Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
- Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 60)
Has Balchem been receiving favorable news coverage?
News headlines about BCPC stock have been trending positive on Friday, Accern reports. Accern rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Balchem earned a news impact score of 0.26 on Accern's scale. They also assigned news stories about the basic materials company an impact score of 46.39 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
Who are Balchem's major shareholders?
Balchem's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.60%), Neuberger Berman Group LLC (4.80%), Wasatch Advisors Inc. (2.60%), Dimensional Fund Advisors LP (2.28%), Royal Bank of Canada (1.70%) and New York State Common Retirement Fund (1.59%). Company insiders that own Balchem stock include Dino A Rossi, Edward Mcmillan, Matthew David Houston and William A Backus. View Institutional Ownership Trends for Balchem.
Which major investors are selling Balchem stock?
BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Neuberger Berman Group LLC, Eagle Asset Management Inc., PNC Financial Services Group Inc., Cortina Asset Management LLC, New York State Common Retirement Fund, Sei Investments Co. and Royal Bank of Canada. View Insider Buying and Selling for Balchem.
Which major investors are buying Balchem stock?
BCPC stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Carillon Tower Advisers Inc., Schwab Charles Investment Management Inc., JPMorgan Chase & Co., MetLife Investment Advisors LLC, Russell Investments Group Ltd., Rhumbline Advisers and Van ECK Associates Corp. View Insider Buying and Selling for Balchem.
How do I buy shares of Balchem?
Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Balchem's stock price today?
One share of BCPC stock can currently be purchased for approximately $99.23.
How big of a company is Balchem?
Balchem has a market capitalization of $3.18 billion and generates $594.79 million in revenue each year. Balchem employs 1,165 workers across the globe.
How can I contact Balchem?
Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]
MarketBeat Community Rating for Balchem (BCPC)
MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote "Outperform" if you believe BCPC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days.
